Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KORU Medical Systems, Inc.KRMD · Entity 6517 | Director | March 31, 2022 | April 04, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KORU Medical Systems, Inc.
Report date March 31, 2022 · Filed April 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,746 |
Reported balance
After 2022-03-31 transaction · row 1
1 source rowRow 1 · 2022-03-31 · Grant · Acquired 5,221 · Balance 58,746 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Longevity Health Holdings, Inc.
Report date August 28, 2024 · Filed August 30, 2024
Section 16 reporting ended · disclosed 2024-08-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Carmell Insiders LLC | 8,128 |
Last balance in matching sequence
After 2024-08-29 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2024-08-28 · Purchase · Acquired 749 · Balance 7,476 F1: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Row 2 · 2024-08-29 · Purchase · Acquired 652 · Balance 8,128 F1: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. |
| Common StockSEC Table I · non-derivative | Direct | 69,504 |
Reported balance
Holding disclosure · report date 2024-08-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 69,504 F2: The shares beneficially owned by the Reporting Person include 69,504 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of the date of this filing. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC.
F2: The shares beneficially owned by the Reporting Person include 69,504 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of the date of this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 29, 2024 Filed Aug 30, 2024 16:30 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 652 | $0.56 | $365.12 |
DisclosureSEC source: 0000950170-24-102369 · ownership.xml · nonDerivative · entry 2 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 8,128 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 16:30 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 749 | $0.56 | $419.44 |
DisclosureSEC source: 0000950170-24-102369 · ownership.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 7,476 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 17:10 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 739 | $3.94 | $2,908.04 |
DisclosureSEC source: 0000950170-23-071162 · ownership.xml · nonDerivative · entry 2 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 6,727 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.93 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 17:10 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 391 | $3.61 | $1,412.25 |
DisclosureSEC source: 0000950170-23-071162 · ownership.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 5,988 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.40 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 13, 2023 Filed Dec 13, 2023 21:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,087 | $5.57 | $6,056.00 |
DisclosureSEC source: 0000950170-23-070165 · ownership.xml · nonDerivative · entry 3 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 5,597 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.47 to $3.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,087 | $3.50 | $3,806.24 |
DisclosureSEC source: 0000950170-23-070165 · ownership.xml · nonDerivative · entry 2 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 4,510 F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 21:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,087 | $3.53 | $3,833.96 |
DisclosureSEC source: 0000950170-23-070165 · ownership.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 3,423 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 21:19 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-069165 · ownership.xml · nonDerivative · entry 6 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,472 F4 · balance_after: The shares beneficially owned by the Reporting Person consist of 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 8, 2023. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 21:19 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 46 | $3.15 | $144.90 |
DisclosureSEC source: 0000950170-23-069165 · ownership.xml · nonDerivative · entry 5 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 2,336 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 21:19 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 248 | $3.07 | $760.32 |
DisclosureSEC source: 0000950170-23-069165 · ownership.xml · nonDerivative · entry 4 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 2,290 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.01 to $3.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 21:19 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 608 | $3.03 | $1,844.00 |
DisclosureSEC source: 0000950170-23-069165 · ownership.xml · nonDerivative · entry 3 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 2,042 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.99 to $3.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 05, 2023 Filed Dec 8, 2023 21:19 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 347 | $3.10 | $1,077.37 |
DisclosureSEC source: 0000950170-23-069165 · ownership.xml · nonDerivative · entry 2 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 1,434 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 04, 2023 Filed Dec 8, 2023 21:19 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,087 | $3.00 | $3,259.26 |
DisclosureSEC source: 0000950170-23-069165 · ownership.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 1,087 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:32 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 32,173 | Not disclosed Strike: $2.11 | Not disclosed |
DisclosureSEC source: 0001062993-23-015050 · form4.xml · derivative · entry 4 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,173 Underlying: Common Stock · 32,173 shares Expires 2031-09-23 F4 · price: On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation. F3 · derivative.exercise_date: Options to purchase 32,173 shares of common stock of Legacy Carmell granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2022 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:32 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 8,509 | Not disclosed Strike: $2.27 | Not disclosed |
DisclosureSEC source: 0001062993-23-015050 · form4.xml · derivative · entry 3 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,509 Underlying: Common Stock · 8,509 shares Expires 2029-07-19 F4 · price: On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation. F2 · derivative.exercise_date: Options to purchase 8,509 shares of common stock of Legacy Carmell (as defined below) granted on July 19, 2019, which vest as follows: (i) 25% vested on July 19, 2020, July 19, 2021 and July 19, 2022 and the remaining 25% will vest on July 19, 2023. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:32 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 19,910 | Not disclosed Strike: $1.79 | Not disclosed |
DisclosureSEC source: 0001062993-23-015050 · form4.xml · derivative · entry 2 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,910 Underlying: Common Stock · 19,910 shares Expires 2027-06-20 F4 · price: On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation. F1 · derivative.exercise_date: Options are fully vested and exercisable. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:32 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 16,285 | Not disclosed Strike: $1.79 | Not disclosed |
DisclosureSEC source: 0001062993-23-015050 · form4.xml · derivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,285 Underlying: Common Stock · 16,285 shares Expires 2026-07-16 F4 · price: On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation. F1 · derivative.exercise_date: Options are fully vested and exercisable. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:11 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,221 | $2.87 | $14,984.27 |
DisclosureSEC source: 0001161697-22-000151 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,746 Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:17 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001161697-22-000004 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,525 Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:05 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,263 | $2.85 | $14,999.55 |
DisclosureSEC source: 0001161697-21-000462 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,525 Read SEC document |
| September 30, 2021 Filed Dec 27, 2021 21:55 UTC Amendment | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,263 | $2.85 | $14,999.55 |
DisclosureSEC source: 0001161697-21-000592 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,525 Read SEC document |
| September 23, 2021 Filed Dec 13, 2023 21:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-070165 · ownership.xml · nonDerivative · entry 4 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,472 F4 · balance_after: The shares beneficially owned by the Reporting Person consist of 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 13, 2023. Read SEC document |
| September 23, 2021 Filed Dec 18, 2023 17:10 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-071162 · ownership.xml · nonDerivative · entry 3 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,472 F4 · kind: The shares beneficially owned by the Reporting Person include 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 18, 2023. F4 · balance_after: The shares beneficially owned by the Reporting Person include 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 18, 2023. Read SEC document |
| June 30, 2021 Filed Jul 6, 2021 23:12 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 2,263 | $4.63 | $10,477.69 |
DisclosureSEC source: 0001161697-21-000324 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,262 Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 18:22 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 1,775 | $3.52 | $6,248.00 |
DisclosureSEC source: 0001161697-21-000186 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,999 Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 00:50 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 1,246 | $6.02 | $7,500.92 |
DisclosureSEC source: 0001161697-21-000031 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,224 Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:10 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 1,039 | $7.22 | $7,501.58 |
DisclosureSEC source: 0001161697-20-000424 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,978 Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 00:04 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 835 | $8.98 | $7,498.30 |
DisclosureSEC source: 0001161697-20-000281 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,939 Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 20:46 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 1,000 | $7.50 | $7,500.00 |
DisclosureSEC source: 0001161697-20-000134 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,104 Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 21:49 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 1,149 | $6.53 | $7,502.97 |
DisclosureSEC source: 0001161697-20-000004 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,104 Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:37 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 1,899 | $3.95 | $7,501.05 |
DisclosureSEC source: 0001161697-19-000410 · form_4.xml · nonDerivative · entry 2 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,955 Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:54 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 3,148 | $2.88 | $9,066.24 |
DisclosureSEC source: 0001161697-19-000279 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,772 Read SEC document |
| June 28, 2019 Filed Jul 23, 2019 21:00 UTC Amendment | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 2,428 | $2.88 | $6,992.64 |
DisclosureSEC source: 0001161697-19-000313 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,052 Read SEC document |
| June 28, 2019 Filed Oct 2, 2019 21:37 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 4 | $2.88 | $11.52 |
DisclosureSEC source: 0001161697-19-000410 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,056 Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 21:29 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 3,906 | $1.60 | $6,249.60 |
DisclosureSEC source: 0001161697-19-000129 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,624 Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 23:28 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 1,894 | $1.65 | $3,125.10 |
DisclosureSEC source: 0001161697-19-000006 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,718 Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 21:59 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 1,894 | $1.65 | $3,125.10 |
DisclosureSEC source: 0001161697-18-000464 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,824 Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:42 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 2,264 | $1.38 | $3,124.32 |
DisclosureSEC source: 0001161697-18-000347 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,930 Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 19:57 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 2,404 | $1.30 | $3,125.20 |
DisclosureSEC source: 0001161697-18-000170 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,666 Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 22:38 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 2,500 | $1.25 | $3,125.00 |
DisclosureSEC source: 0001161697-18-000008 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,262 Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 01:44 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 5,896 | $0.53 | $3,124.88 |
DisclosureSEC source: 0001161697-17-000429 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,762 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:55 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 8,866 | $0.47 | $4,167.02 |
DisclosureSEC source: 0001161697-17-000306 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,866 Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 20:52 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | SaleCommon Stock | 7,353 | $0.40 | $2,941.20 |
DisclosureSEC source: 0001161697-17-000272 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents shares issued to the Reporting Person in lieu of fees for service as a director of the Company pursuant to transactions exempt under Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 17, 2017 Filed May 25, 2017 21:39 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | SaleCommon Stock | 23,315 | $0.40 | $9,326.00 |
DisclosureSEC source: 0001161697-17-000263 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,862 F1 · shares: Represents shares issued to the Reporting Person in lieu of fees for service as a director of the Company pursuant to transactions exempt under Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 17, 2017 Filed May 31, 2017 01:16 UTC Amendment | KORU Medical Systems, Inc. REPR · Entity 6517 | SaleCommon Stock | 23,315 | $0.40 | $9,326.00 |
DisclosureSEC source: 0001161697-17-000270 · form_4.xml · nonDerivative · entry 4 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,353 F2 · balance_after: As a result of the incorrect number of shares reported on in the reporting person's Form 4 filed on October 27, 2016, the amount of securities beneficially owned following reported transactions were then also reported incorrectly on his Form 4's with transaction dates of March 2, 2017 and May 17, 2017. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:21 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 6,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-17-000139 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,824 Read SEC document |
| March 01, 2017 Filed May 2, 2017 21:38 UTC Amendment | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 7,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-17-000222 · form_4.xml · nonDerivative · entry 2 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,177 Read SEC document |
| March 01, 2017 Filed May 2, 2017 21:38 UTC Amendment | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 6,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-17-000222 · form_4.xml · nonDerivative · entry 1 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,824 Read SEC document |
| March 01, 2017 Filed May 31, 2017 01:16 UTC Amendment | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 7,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-17-000270 · form_4.xml · nonDerivative · entry 3 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,177 F2 · balance_after: As a result of the incorrect number of shares reported on in the reporting person's Form 4 filed on October 27, 2016, the amount of securities beneficially owned following reported transactions were then also reported incorrectly on his Form 4's with transaction dates of March 2, 2017 and May 17, 2017. Read SEC document |
| March 01, 2017 Filed May 31, 2017 01:16 UTC Amendment | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 6,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-17-000270 · form_4.xml · nonDerivative · entry 2 Anderson David W · CIK 0001304554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,315 F2 · balance_after: As a result of the incorrect number of shares reported on in the reporting person's Form 4 filed on October 27, 2016, the amount of securities beneficially owned following reported transactions were then also reported incorrectly on his Form 4's with transaction dates of March 2, 2017 and May 17, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.